Small pharma companies seek price caps on inputs as costs surge

Indian pharmaceutical units face a severe crisis. Input costs have surged by 200-300 percent. This is due to global conflicts disrupting raw material supply. The Himachal Drug Manufacturers Association seeks government intervention. They want emergency price controls and a crisis task force. This aims to protect the industry and ensure medicine availability.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nXC5bIZ
via IFTTT